Related Experiment Videos
Alzheimer's disease and brain development: common molecular pathways
1Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Frontiers in Bioscience : a Journal and Virtual Library
|February 27, 1998
Summary
Alzheimer's disease (AD) progression may be driven by the re-expression of genes normally active during brain development. This research suggests these genes play a critical role in the disease's molecular mechanisms.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Alzheimer's disease (AD) research has explored various causes and treatments.
- Current models of AD do not fully explain neuropathological findings or the role of aging.
- The precise mechanisms driving AD progression remain largely unknown.
Purpose of the Study:
- To investigate the role of alternative gene expression in Alzheimer's disease progression.
- To explore the hypothesis that re-expressed developmentally regulated genes are critical in AD.
Main Methods:
- Analysis of gene expression patterns in Alzheimer's disease.
- Identification of re-expressed or activated genes, including transcription factors and cell cycle proteins.
- Comparison of gene expression profiles in AD with those during normal brain development.
Main Results:
- Numerous developmentally regulated genes and cell cycle proteins are re-expressed or activated in Alzheimer's disease.
- These proteins include transcription factors, cell cycle regulators, and programmed cell death genes.
- The re-expression of these proteins suggests shared molecular mechanisms between brain development and AD.
Conclusions:
- Alternative gene expression, particularly of developmentally regulated genes, is hypothesized to be a critical factor in Alzheimer's disease progression.
- The re-activation of genes crucial for brain development may contribute to the neuropathology observed in AD.
- Understanding these molecular mechanisms could offer new therapeutic targets for Alzheimer's disease.